Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference


AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that Eric Easom, Co-Founder, President and CEO will present at the SVB Securities Global Biopharma Conference.

Details of the event is as follows:

SVB Securities Global Biopharma Conference, February 14-15, 2023 (virtual)

A webcast of the presentation can be accessed on the Investors section of the AN2 Therapeutics website at www.an2therapeutics.com. An archived replay will be available for at least 30 days following the presentation.

About AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Our lead candidate is epetraborole, which we are studying in a pivotal Phase 2/3 trial as a once-daily, oral treatment with a novel mechanism of action for patients with NTM lung disease, a rare, chronic, and progressive infectious disease caused by bacteria, known as mycobacteria, that leads to irreversible lung damage and can be fatal. For more information, please visit our website at www.an2therapeutics.com.


These press releases may also interest you

at 03:31
Askel Healthcare has reached an important milestone towards marketing authorization of the COPLA® implant in EU and the USA
Finnish medical technology company Askel Healthcare is developing a new method to treat knee cartilage defects. Askel Healthcare's COPLA® implant is expected to significantly accelerate rehabilitation and enable healing of damaged knee cartilage....

at 03:30
OneThird Raises $3 Million to Tackle the $1 Trillion Lost to Food Waste Annually
OneThird, an AI-powered food tech company created to address the annual loss of one-third of all food produced due to spoilage, today announced the company has raised $3M (2.75M euros) in a late-seed funding...

at 03:05
Xperi's DTS AutoStage Unleashes the Power of In-Car Audience Analytics for Radio Broadcasters
DTS, Inc., a global leader in next-generation audio, imaging and sensing technology and a wholly owned subsidiary of Xperi Inc. , today announced the global launch of DTS AutoStagetm Broadcaster Portal ? giving radio broadcasters access to data on...

at 03:05
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty Pharma , the largest buyer of biopharmaceutical royalties and a leading...

at 03:05
ESI Group Reveals Bold Rebranding to Celebrate 50 Years and Marks the Beginning of a Next Chapter
Regulatory News: ESI Group (ISIN Code: FR0004110310, Symbol: ESI), the world-renowned simulation and virtual prototyping software provider for the industry, announces a dynamic new brand identity to mark its 50th anniversary. The company's cultural...

at 03:00
New generative AI solution from Market Logic Software, DeepSightstm, places trusted market insights at the fingertips of business decision-makers 24/7
Market Logic Software, the global leader for insights management solutions, is today announcing general availability of DeepSightstm, the world's first AI Assistant trained to answer business questions about market research and intelligence. The...

More news about Science and technology...


News published on 31 january 2023 at 16:15 and distributed by: